ES2084787T3 - Nutricion. - Google Patents

Nutricion.

Info

Publication number
ES2084787T3
ES2084787T3 ES91311260T ES91311260T ES2084787T3 ES 2084787 T3 ES2084787 T3 ES 2084787T3 ES 91311260 T ES91311260 T ES 91311260T ES 91311260 T ES91311260 T ES 91311260T ES 2084787 T3 ES2084787 T3 ES 2084787T3
Authority
ES
Spain
Prior art keywords
parenteral
nutrition
compositions
enteral
efas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91311260T
Other languages
English (en)
Inventor
David F Horrobin
Lars Lindmark
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scotia Holdings PLC
Original Assignee
Scotia Holdings PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scotia Holdings PLC filed Critical Scotia Holdings PLC
Application granted granted Critical
Publication of ES2084787T3 publication Critical patent/ES2084787T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pediatric Medicine (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Seeds, Soups, And Other Foods (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

EFECTOS LATERALES OPUESTOS DE NUTRICION FLUIDA NO INTESTINAL O INTESTINAL MEDIANTE LA ADICION DE UNO O MAS ACIDOS GRASOS ESENCIALES 6-DESATURADOS (EFAS) A UNA COMPOSICION NO INTESTINAL O INTESTINAL (PARTICULARMENTE COMPOSICIONES BAJAS EN GRASAS), SIENDO DADOS O DANDOLOS EN ADICION A LAS COMPOSICIONES.
ES91311260T 1990-12-07 1991-12-04 Nutricion. Expired - Lifetime ES2084787T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909026648A GB9026648D0 (en) 1990-12-07 1990-12-07 Nutrition

Publications (1)

Publication Number Publication Date
ES2084787T3 true ES2084787T3 (es) 1996-05-16

Family

ID=10686652

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91311260T Expired - Lifetime ES2084787T3 (es) 1990-12-07 1991-12-04 Nutricion.

Country Status (13)

Country Link
EP (2) EP0682878A3 (es)
JP (1) JPH04290821A (es)
AT (1) ATE135535T1 (es)
AU (1) AU652785B2 (es)
CA (1) CA2056957A1 (es)
DE (1) DE69118130T2 (es)
DK (1) DK0490561T3 (es)
ES (1) ES2084787T3 (es)
GB (1) GB9026648D0 (es)
GR (1) GR3020173T3 (es)
IE (1) IE72221B1 (es)
NZ (1) NZ240841A (es)
ZA (1) ZA919571B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5308832A (en) * 1992-07-27 1994-05-03 Abbott Laboratories Nutritional product for persons having a neurological injury
EP0711503A3 (en) * 1994-11-14 1997-11-26 Scotia Holdings Plc Milk fortified with GLA and/or DGLA
GB9617847D0 (en) 1996-08-27 1996-10-09 Scotia Holdings Plc Fatty acid treatment
WO1998041216A1 (en) * 1997-03-17 1998-09-24 Tam Yun K Composition for prevention of hepatic steatosis
JP4129566B2 (ja) * 1997-09-05 2008-08-06 大塚製薬株式会社 肝臓脂肪蓄積抑制組成物及び肝臓脂肪蓄積抑制用食品添加剤
DE19757414A1 (de) 1997-12-23 1999-07-01 Nutricia Nv Fettmischung
GB9923738D0 (en) * 1999-10-07 1999-12-08 Nestle Sa Nutritional composition
US7981915B2 (en) 2003-04-30 2011-07-19 Beth Israel Deaconess Medical Center Methods for modulating PPAR biological activity for the treatment of diseases caused by mutations in the CFTR gene
GB0311081D0 (en) 2003-05-14 2003-06-18 Btg Internat Limted Treatment of neurodegenerative conditions
AU2004266480B2 (en) 2003-08-18 2011-03-03 Btg International Limited Treatment of neurodegenerative conditions
GB0504362D0 (en) 2005-03-02 2005-04-06 Btg Int Ltd Cytokine modulators
US20100120914A1 (en) * 2007-03-30 2010-05-13 Kowa Company, Ltd. Medicament for prophylactic and/or therapeutic treatment of hepatic steatosis or non-alcoholic steatohepatitis
WO2009060452A2 (en) * 2007-11-08 2009-05-14 Galmed International Ltd. Methods and compositions for treating biliary cholesterol crystallization and related conditions
JP7422160B2 (ja) * 2019-10-01 2024-01-25 サントリーホールディングス株式会社 アクアポリン３の発現調節を介した腸機能改善用組成物及びその使用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56122312A (en) * 1980-02-29 1981-09-25 Kagakuhin Kensa Kyokai Hepatic cholesterol-lowering agent (hepatic decholesterolizing agent)
GB8319073D0 (en) * 1983-07-14 1983-08-17 Efamol Ltd Fatty acid compositions
JPS60169418A (ja) * 1984-02-15 1985-09-02 Nippon Oil & Fats Co Ltd 胆石症の予防および治療剤
US4752618A (en) * 1984-07-12 1988-06-21 New England Deaconess Hospital Method of minimizing efects of infection through diet
AU596880B2 (en) * 1986-09-17 1990-05-17 Clintec Nutrition Company Liquid nutritional compositions
SE8604117D0 (sv) * 1986-09-29 1986-09-29 Kabivitrum Ab Composition
JPS63297342A (ja) * 1987-05-28 1988-12-05 Nisshin Oil Mills Ltd:The 合成油脂ならびにこれを含有する脂肪乳剤輸液および経腸栄養剤
DE3721137A1 (de) * 1987-06-26 1989-01-05 Dietl Hans Fettemulsion zur intravenoesen anwendung
DE3734147C2 (de) * 1987-10-09 1998-10-29 Braun Melsungen Ag Isotone omega-3-fettsäurenhaltige Fettemulsion und ihre Verwendung
GB8813766D0 (en) * 1988-06-10 1988-07-13 Efamol Holdings Essential fatty acid compositions

Also Published As

Publication number Publication date
EP0490561A2 (en) 1992-06-17
CA2056957A1 (en) 1992-06-08
AU652785B2 (en) 1994-09-08
EP0682878A2 (en) 1995-11-22
ZA919571B (en) 1992-11-25
IE72221B1 (en) 1997-04-09
GR3020173T3 (en) 1996-09-30
JPH04290821A (ja) 1992-10-15
ATE135535T1 (de) 1996-04-15
EP0682878A3 (en) 1998-01-14
DE69118130D1 (de) 1996-04-25
GB9026648D0 (en) 1991-01-23
NZ240841A (en) 1997-07-27
AU8839791A (en) 1992-06-11
EP0490561B1 (en) 1996-03-20
DE69118130T2 (de) 1996-10-02
IE914174A1 (en) 1992-06-17
DK0490561T3 (da) 1996-04-15
EP0490561A3 (en) 1992-10-07

Similar Documents

Publication Publication Date Title
BR9205526A (pt) Misturas de oleos microbianos e usos dos mesmos
ATE142435T1 (de) Nahrhafte zusammensetzung
DE3887247D1 (de) Feste unverdauliche fettähnliche Verbindungen.
ES2084787T3 (es) Nutricion.
PH25552A (en) Composition containing novel solid nondigestible fat-like compound
ATE81453T1 (de) Essentielle fettsaeure enthaltende zusammensetzungen.
DE69120533D1 (de) Neue feste unverdauliche fettähnliche verbindungen und diese enthaltende nahrungsmittelzusammensetzungen
AU566077B2 (en) 2,6-bis-fluoromethyl-dihydropyridine-3, 5-dicarboxylic
ATE31623T1 (de) Injizierbare zusammensetzungen von bbm-928a.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 490561

Country of ref document: ES